Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like Symptoms

NAUnknownINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Severe Influenza
Interventions
DRUG

Oseltamivir Phosphate

Take the dosage of Oseltamivir Phosphate recommended according to the instructions.support treatment such as antiasthmatic, expectorant and antipyretic use only in need.

DRUG

Xiyanping injection+Oseltamivir Phosphate

Take the dosage of Oseltamivir Phosphate recommended according to the instructions.Xiyanping injection intravenous administration of 0.4mL/kg/day ,QD for 7-10 days.support treatment such as antiasthmatic, expectorant and antipyretic use only in need.

Trial Locations (1)

Unknown

RECRUITING

The First Affliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin

All Listed Sponsors
collaborator

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

OTHER

collaborator

Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

OTHER

collaborator

Beijing Luhe Hospital

OTHER

collaborator

Qingdao Municipal Hospital

OTHER

collaborator

Cangzhou People's Hospital

OTHER

lead

Jiangxi Qingfeng Pharmaceutical Co. Ltd.

INDUSTRY